Q3 2024 · 13F-HR
Affinity Asset Advisors, LLCholdings as filed
Filed 2024-11-13 · accession 0001839882-24-038904
$732.8M
Reported value
86
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $45.0M | 6.15% | 1,144,021 | Common | SOLE |
| 14817C107 | FLNA | CASSAVA SCIENCES INC | $42.7M | 5.82% | 1,449,300 | PUT | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $39.0M | 5.32% | 664,198 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $34.5M | 4.71% | 337,500 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $33.4M | 4.56% | 400,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $28.0M | 3.82% | 1,000,000 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $25.2M | 3.44% | 1,400,000 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $21.2M | 2.90% | 100,000 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $20.4M | 2.79% | 400,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $19.3M | 2.64% | 860,399 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $19.2M | 2.62% | 435,000 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $18.7M | 2.55% | 650,000 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $18.0M | 2.46% | 1,000,000 | CALL | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $16.3M | 2.23% | 4,500,000 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $15.4M | 2.11% | 965,612 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $14.8M | 2.01% | 2,822,318 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $14.7M | 2.00% | 498,420 | Common | SOLE |
| 682143AG7 | OMER 5.25 02/15/26 | OMEROS CORP | $14.6M | 2.00% | 21,525,000 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $13.4M | 1.83% | 687,785 | Common | SOLE |
| 19249HAB9 | — | COHERUS BIOSCIENCES INC | $13.1M | 1.78% | 16,625,000 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $12.6M | 1.72% | 290,447 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $11.9M | 1.63% | 525,000 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $11.5M | 1.57% | 1,400,000 | Common | SOLE |
| 48576UAA4 | — | KARYOPHARM THERAPEUTICS INC | $9.6M | 1.31% | 12,250,000 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $8.6M | 1.17% | 349,836 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $8.2M | 1.13% | 1,700,000 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $8.1M | 1.10% | 161,741 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $8.0M | 1.09% | 725,106 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $7.9M | 1.07% | 35,000 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $7.8M | 1.07% | 472,390 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $7.6M | 1.04% | 300,000 | Common | SOLE |
| 28658R106 | CLYM | ELIEM THERAPEUTICS INC | $7.6M | 1.04% | 1,500,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $7.2M | 0.98% | 80,000 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $6.8M | 0.93% | 2,499,431 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $6.8M | 0.93% | 1,500,000 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $6.7M | 0.91% | 200,000 | PUT | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $6.7M | 0.91% | 500,000 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $6.4M | 0.88% | 225,000 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $6.3M | 0.86% | 325,000 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $5.8M | 0.79% | 400,000 | CALL | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $5.7M | 0.78% | 50,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $5.5M | 0.76% | 225,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $5.0M | 0.68% | 600,000 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $4.7M | 0.64% | 147,500 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $4.4M | 0.60% | 263,817 | Common | SOLE |
| 89422GAA5 | TVTX 2.25 03/01/29 | TRAVERE THERAPEUTICS INC | $4.3M | 0.59% | 5,000,000 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $4.2M | 0.58% | 125,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $4.2M | 0.58% | 350,000 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $3.8M | 0.52% | 300,000 | CALL | SOLE |
| 457669307 | INSM | INSMED INC | $3.6M | 0.50% | 50,000 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $3.5M | 0.48% | 350,000 | Common | SOLE |
| 363225202 | GALT | GALECTIN THERAPEUTICS INC | $3.3M | 0.45% | 1,211,400 | PUT | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $3.2M | 0.43% | 2,302,598 | Common | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS INC | $3.1M | 0.42% | 140,000 | CALL | SOLE |
| 805111101 | SVRA | SAVARA INC | $3.0M | 0.41% | 700,000 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $2.9M | 0.40% | 650,000 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $2.9M | 0.40% | 75,000 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $2.9M | 0.39% | 250,000 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $2.7M | 0.36% | 1,234,200 | PUT | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $2.6M | 0.36% | 250,000 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $2.6M | 0.35% | 1,321,153 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $2.5M | 0.34% | 60,000 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $2.3M | 0.32% | 201,587 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $2.2M | 0.30% | 78,000 | CALL | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $1.9M | 0.27% | 2,511,778 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $1.9M | 0.26% | 300,512 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $1.8M | 0.24% | 58,331 | Common | SOLE |
| N62509117 | NAMSW | NEWAMSTERDAM PHARMA COMPANY | $1.5M | 0.20% | 212,974 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $1.3M | 0.17% | 25,000 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $1.3M | 0.17% | 600,000 | Common | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $1.2M | 0.17% | 27,777 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $1.2M | 0.16% | 400,000 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $1.1M | 0.14% | 15,000 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $906,740 | 0.12% | 223,335 | Common | SOLE |
| 74587V107 | PBYI | PUMA BIOTECHNOLOGY INC | $637,500 | 0.09% | 250,000 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $596,327 | 0.08% | 173,351 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $586,311 | 0.08% | 119,900 | Common | SOLE |
| 00534B100 | ADGM | ADAGIO MED HLDGS INC | $550,146 | 0.08% | 213,235 | Common | SOLE |
| N44445117 | IMTXW | IMMATICS N.V | $430,569 | 0.06% | 187,204 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $425,700 | 0.06% | 45,000 | Common | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $302,603 | 0.04% | 51,727 | Common | SOLE |
| 64132R404 | — | NEUROBO PHARMACEUTICALS IN | $282,834 | 0.04% | 89,222 | Common | SOLE |
| 36870H103 | GNLX | GENELUX CORPORATION | $237,000 | 0.03% | 100,000 | Common | SOLE |
| 00032Q104 | WHWK | AADI BIOSCIENCE INC | $96,859 | 0.01% | 47,019 | Common | SOLE |
| 74346M406 | PMNEUR | PROMIS NEUROSCIENCES INC | $38,304 | 0.01% | 30,643 | Common | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $5,250 | 0.00% | 75,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.